# Supreme Court quashes Rs 5 lakh compensation against FDA

2026-10-06T00:37:51+00:00 | Governance | Indian Opinion Desk

Corroboration: 5 independent outlets

The Supreme Court on Monday, 5 October 2026, set aside a Bombay High Court order directing the Maharashtra Food and Drug Administration (FDA) to pay Rs 5 lakh compensation to a Pune sweet shop, M/s Gurunanak Dairy & Sweets. The FDA had suspended the shop’s licence in June following a food poisoning complaint and an inspection that found hygiene, labelling and sanitation deficiencies. A sample of Malai Pedha was declared unsafe. The Bombay High Court on 17 August revoked the suspension and directed the FDA to pay Rs 5 lakh for the business losses. The state government appealed, arguing the FDA acted promptly, without malice, and that the law bars compensation in such cases. The Supreme Court accepted the state’s submissions and quashed the compensation, holding the FDA action was in the interest of public health.

## Indian Opinion Analysis

The Times of India reports the Supreme Court quashed costs the High Court ‘saddled’ the FDA with, and notes the FDA commissioner is Tukaram Mundhe. Free Press Journal, India Today, Mid-Day and The Hindu all report the court held the FDA action was in the public interest. The Times of India alone omits the ‘public interest’ justification and leads with the FDA’s relief. Free Press Journal and The Hindu add that the shop’s statutory appeal was pending before the FDA Commissioner. The coverage is otherwise uniform factual reporting. The Supreme Court’s order leaves the regulatory suspension and the pending appeal intact.

## Coverage

Coverage: 5 sources, 1 pro-government, 4 neutral
- timesofindia.indiatimes.com (neutral report) <https://timesofindia.indiatimes.com/city/mumbai/supreme-court-sets-aside-rs-5-lakh-compensation-cost-imposed-on-fda-by-bombay-high-court/articleshow/134710610.cms>
  Leads with FDA relief, omits public interest justification
- freepressjournal.in (pro government) <https://www.freepressjournal.in/mumbai/supreme-court-quashes-5-lakh-compensation-to-pune-dairy-backs-maharashtra-fda-action-over-unsafe-food-sample>
  Leads with court backing FDA action over unsafe sample
- indiatoday.in (neutral report) <https://www.indiatoday.in/india/law-news/story/supreme-court-sets-aside-bombay-high-court-compensation-order-in-gurunanak-dairy-fda-case-3010217-2026-10-05?utm_source=rss>
  Straight factual reporting, includes both sides
- mid-day.com (neutral report) <https://www.mid-day.com/news/india-news/article/pune-dairy-case-supreme-court-quashes-rs-5-lakh-compensation-order-against-maharashtra-fda-23653518>
  Minimal detail, brief factual summary
- thehindu.com (neutral report) <https://www.thehindu.com/news/national/supreme-court-quashes-bombay-hc-order-directing-maharashtra-fda-to-pay-5-lakh-compensation/article71548545.ece>
  Detailed timeline, press note based, factual

This brief was synthesised by AI from the 5 sources linked above, so one read covers every framing they carry.

Tags: Bombay High Court, Food Safety and Standards Act, Gurunanak Dairy and Sweets, Maharashtra FDA, Supreme Court
Canonical: https://indianopinion.org/supreme-court-quashes-rs-5-lakh-compensation-against-fda/
License: Summary and commentary (c) Indian Opinion, reusable with attribution. Facts belong to the linked sources.
Cite: https://indianopinion.org/supreme-court-quashes-rs-5-lakh-compensation-against-fda/#story-in-brief

How this brief was made: an AI model read the reports linked above and wrote this summary and analysis, which were published automatically. Published briefs are sampled every hour by an automated quality check; the editor verifies its findings and approves corrections, and corrected briefs carry a dated correction line. Stance labels are editorial classifications of how each outlet framed this story, assigned by the same model, not ratings of the outlets. We do no original reporting. Methodology: https://indianopinion.org/ai-use-policy/
